David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 1,028,304 shares at $4.38 ($4.5M) on 2024-10-21, disclosed to the SEC on 2024-10-22.
Scheduled sale ($4.5M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.38 | 245,784 | $1.1M | 23.9% |
| 2 | $4.38 | 245,784 | $1.1M | 23.9% |
| 3 | $4.38 | 110,456 | $484K | 10.7% |
| 4 | $4.38 | 110,456 | $484K | 10.7% |
| 5 | $4.39 | 157,912 | $693K | 15.4% |
| 6 | $4.39 | 157,912 |
| $693K |
| 15.4% |
| Total | $4.38 avg | 1,028,304 | $4.5M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |